The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...
GlobalData on MSN
FDA clears Roche’s blood-based test for Alzheimer’s assessment
The US Food and Drug Administration (FDA) has granted clearance for Roche's Elecsys pTau181 test, a blood-based biomarker ...
14hon MSN
Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease
Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are ...
Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s ...
Recent Food and Drug Administration approval of the first two blood tests used in detecting Alzheimer’s disease brings hope ...
The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).
US FDA clears Roche’s Elecsys pTau181 test, the only BBM test for use in primary care to rule out Alzheimer’s-related amyloid pathology: Basel Wednesday, October 15, 2025, 10: ...
Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...
Dear Savvy Senior, Are there any proven strategies to preventing cognitive decline? I have a family history of dementia and worry about my own memory and cognitive abilities as I grow older. — ...
News-Medical.Net on MSN
Quitting smoking linked to slower memory decline in midlife and older adults
The study, published in The Lancet Healthy Longevity, looked at data from 9,436 people aged 40 or over (with an average age ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback